By proceeding, you agree to our Terms of Use and Privacy Policy.
Dr. Hare co-founded Longeveron in 2014 and serves as Chairman of the Board of Directors, and Chief Science Officer. Dr.
Talks About #Business #innovation #leadership
Preferred Locations #NorthAmerica
We're excited to announce that Drug Target Review will be hosting its first ever online summit on Cell & Gene Therapy Advancements and are inviting you to join us for FREE.
